News in brief

Supply woes cut Clorox’s supplement sales, but sanitizer demand more than fills gap

By Hank Schultz

- Last updated on GMT

© Getty Images Oatawa
© Getty Images Oatawa
Based on strong sales of its cleaning products, The Clorox Company has increased its stock dividend. But supply bottlenecks meant sales of the company’s dietary supplements fell, bucking an industry trend.

Yesterday the board of directors for Clorox, which has a strong history of dividend growth, approved a 5% hike taking the dividend from $1.06 to $1.11 a share.  The company’s stock price also rose on the news that it had entered into a partnership with United Airlines to use Clorox cleaning and disinfectant products in a ramped up sanitizing and social distancing protocol program that the airline unveiled yesterday in an effort to woo back frightened travelers.  The Cleveland Clinic has also signed on as a partner in the program.

Clorox owns a number of dietary supplement and personal care brands including RenewLife, Rainbow Light, Natural Vitality and NeoCell dietary supplements and the Burt’s Bees line of topical products.  The company’s recent earnings statement Clorox stated that dietary supplement sales fell 2% in its third quarter, which the company attributed to a coronavirus-related supply disruption.

Overall sales for the company rose 15% in the third quarter, according to the earnings report. Sales in the company’s cleaning products division increased by 32% in the quarter.

Related news

Show more

Related products

show more

Embrace the Biotic Edge from Gut to Skin

Embrace the Biotic Edge from Gut to Skin

Content provided by CJ BIO | 08-Nov-2024 | White Paper

Searching for ways to stand out in the market? Dive into our report that analyzes the evolution of the biotics market to identify the key elements driving...

Explore the scientific foundations of Nextida™ GC

Explore the scientific foundations of Nextida™ GC

Content provided by Rousselot | 01-Nov-2024 | White Paper

The first commercialised ingredient in the Nextida platform, a range of specific collagen peptide compositions with targeted health benefits, Nextida™...

Your Product Innovation Begins Here: Booth 4055

Your Product Innovation Begins Here: Booth 4055

Content provided by Effepharm Ltd | 22-Oct-2024 | Product Brochure

EffePharm will showcase innovative anti-aging solutions, featuring UthPeak™, world’s first self-GRAS approved NMNH, which boosts NAD+ levels by 10X. UthPeak™...

Related suppliers

Follow us

Products

View more

Webinars